Diagnosis of Bone Metastasis due to Medullary Thyroid Cancer With 99mTc- (V) DMSA SPECT Imaging

Esmaeil Gharepapagh; Jalil Houshyar; Farzad Farajbakhsh Mamaghani; Mahsa Karbasi; Sahar Rezaei

doi:10.1002/ccr3.70018

Diagnosis of Bone Metastasis due to Medullary Thyroid Cancer With ^99mTc- (V) DMSA SPECT Imaging

Clin Case Rep. 2024 Dec 18;12(12):e70018. doi: 10.1002/ccr3.70018. eCollection 2024 Dec.

Authors

Esmaeil Gharepapagh^{1

2}, Jalil Houshyar³, Farzad Farajbakhsh Mamaghani⁴, Mahsa Karbasi⁵, Sahar Rezaei²

Affiliations

¹ Clinical Research Development Unit of Tabriz Valiasr Hospital Tabriz University of Medical Sciences Tabriz Iran.
² Department of Nuclear Medicine, Medical School Tabriz University of Medical Sciences Tabriz Iran.
³ Endocrine Research Center Tabriz University of Medical Sciences Tabriz Iran.
⁴ Radiopharmaceutical Kits Production Pars Isotope Company Tehran Iran.
⁵ Department of Radiology, Medical School Tabriz University of Medical Sciences Tabriz Iran.

Abstract

Given the limited availability of PET/CT scans, ^99mTc-(V) DMSA scintigraphy can be used to investigate possible metastases, especially in bone, in individuals with medullary thyroid cancer, even if there are no noticeable signs or symptoms of pain.

Keywords: 99mTc (V)‐DMSA; MTC; SPECT imaging; medullary thyroid cancer.